Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liquid Biopsy × CNS × 90 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 4 Gastrointestinal 4 Sarcoma 2 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 CNS 1 Breast 1

Conditions

Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1

Interventions

Temozolomide 74 Magnetic Resonance Spectroscopy 65 Specimen Handling 44 Radiotherapy 42 Radiosurgery 28 Cyclophosphamide 27 Radiation 22 pembrolizumab 21 Biopsy 19 Bevacizumab 16 Nivolumab 15 Carboplatin 14 Irinotecan 13 Etoposide 13 Vincristine 11 fludarabine 10 dinutuximab 10 Ipilimumab 10 abemaciclib 9 AZD 6244 9 X-Rays 8 Lomustine 8 trametinib 7 niraparib 7 Topotecan 7 Surgical Procedures, Operative 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 Eflornithine 7 Cisplatin 7 Blood Specimen Collection 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06515860 2026-01-09

NF1-TED

Boston Children's Hospital

Neurofibromatosis 1, Neurofibroma, Plexiform, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡